The phase 3 CanStem111P study was terminated early due to futility.
Jen Smith
Jen Smith is the medical editor of Cancer Therapy Advisor. She was previously the editor of Hematology Times and the oncology editor for MDedge Hematology/Oncology. She has a BS in journalism.